Menu
News
The capital dresses up for science
The European Association of Economy and Competitiveness celebrates the second edition of the Isaac Peral National Award for Research, Science and Innovation The investigation was …
Artificial intelligence: key to optimizing clinical decisions in cancer patients
“The OPS (Oncology Precision System) starts from the genetic characteristics of each patient and is capable of proposing the best combination of treatments currently available …
KeyZell boosts its cancer treatments
Receive an award for an Artificial Intelligence development. KeyZell promotes its cancer treatments and for this it has received an award in the II Edition …
KeyZell Awarded for Treating Cancer with Biotechnology, Artificial Intelligence
06.28.2022 2:48 pm Biotechnological startup Keisel has been honored at the second edition of the Isaac Perel National Research, Science and Innovation Awards organized by …
KeyZell revolutionizes the fight against lung and breast cancer with an Artificial Intelligence tool
The Spanish biotechnology startup KeyZell, in alliance with the technology company Iakan, has presented an Artificial Intelligence solution capable of recommending personalized treatments for lung …
KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn
MADRID, March 17, 2022 /CNW/ — KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing …
Starving glioblastoma, the deadliest brain cancer
Glioblastoma is one of the most common, deadly and difficult to treat brain tumors in adults, only 25% of patients survive more than one year. …
Precision medicine against cancer: create the most appropriate treatments for each patient with AI
KeyZell develops novel oncology drugs and finds the most efficient combination of treatments according to each genetics and clinical history. Covid-19 placed the importance of …
Keyzell and Lãberit join forces to develop artificial intelligence to personalize cancer treatments
Madrid, February 18, 2022. KeyZell, a Spanish biotechnology company focused on the discovery and development of a new generation of anticancer drugs, as well as …
